Introduction: Who Should Undergo Diagnostics

Most people with an intraductal papillary mucinous neoplasm, or IPMN, don’t realize they have it because it typically causes no symptoms in its early stages. The majority of these pancreatic cysts are discovered by chance when someone undergoes imaging tests like a CT scan or MRI for a completely different reason. This is actually good news, because finding these growths early means doctors can keep a close watch on them or treat them before they have a chance to turn into something more dangerous.^[1]

However, certain groups of people should be especially mindful about diagnostic testing. If you experience persistent stomach pain that comes and goes, especially after eating, this could be a warning sign worth investigating. Unintended weight loss, nausea, vomiting, or back pain that doesn’t seem to have an obvious cause may also warrant further testing. Additionally, if you notice your stools have become oily or greasy, or if your skin and the whites of your eyes have started to turn yellow (a condition called jaundice), these are symptoms that require immediate medical attention.^[1][6]

People with a family history of pancreatic cancer are at higher risk of developing IPMNs. If someone in your family has had pancreatic ductal adenocarcinoma (the most common type of pancreatic cancer), it’s important to let your doctor know. This family connection increases your chances of developing these cysts, and your healthcare provider may recommend regular monitoring even before symptoms appear.^[1][2]

Age is another factor to consider. IPMNs are most commonly found in men between the ages of 50 and 70, though they can occur in anyone. Research shows that pancreatic cysts become more common as we get older. In one study, no cysts were found in people under 40, but nearly 9 percent of people between 80 and 89 years old had them. This doesn’t mean everyone in this age group needs testing, but it does mean that if imaging is done for another reason and a cyst is spotted, it should be taken seriously.^[1][14]

Certain health conditions may also prompt your doctor to recommend diagnostic testing. If you’ve been diagnosed with diabetes that has suddenly appeared without clear explanation, especially if you’re older, this could be linked to changes in your pancreas. Similarly, if you develop pancreatitis — inflammation of the pancreas — that can’t be explained by the usual causes like gallstones or alcohol use, an IPMN might be the hidden culprit. The cysts produce a thick, jelly-like substance called mucin that can block the tiny tubes inside the pancreas, leading to painful inflammation.^[1][6]

Diagnostic Methods: How Doctors Identify and Evaluate IPMNs

When doctors suspect or discover an IPMN, they use several different imaging techniques to get a clear picture of what’s happening inside the pancreas. The goal is not just to confirm that a cyst exists, but to understand its size, location, and characteristics — all of which help determine whether it poses a risk of becoming cancerous.

Magnetic Resonance Cholangiopancreatography (MRCP)

The most common and preferred test for diagnosing and monitoring IPMNs is called magnetic resonance cholangiopancreatography, or MRCP for short. This is a special type of MRI scan that creates extremely detailed images of the pancreas, pancreatic ducts, liver, bile ducts, and gallbladder. Unlike a regular MRI, MRCP is specifically designed to highlight the fluid-filled structures inside these organs, making it ideal for spotting cysts and understanding how they’re affecting the pancreatic ducts.^[1][15]

During this test, you’ll lie inside a large, tube-shaped machine while it takes images from multiple angles. The procedure is painless and non-invasive, meaning nothing enters your body. You may hear loud knocking or thumping sounds during the scan, but you can usually wear earplugs or headphones to make it more comfortable. The entire process typically takes between 30 and 60 minutes. For people already diagnosed with an IPMN, MRCP is often repeated at regular intervals to watch for any changes in the cyst over time.^[10]

Computed Tomography (CT) Scan

A CT scan is another imaging tool that doctors use to evaluate pancreatic cysts. This test uses X-rays taken from different angles and combines them with computer processing to create cross-sectional images of your body. CT scans can provide detailed information about the size and structure of an IPMN, making them useful when doctors need to decide on the next steps in care.^[1][10]

Many pancreatic cysts are actually first discovered on CT scans performed for unrelated reasons. For example, someone might have a CT scan because of abdominal pain from a completely different issue, and a cyst shows up unexpectedly. Studies have found that between 2.6 and 13.5 percent of adults who undergo abdominal imaging have pancreatic cysts, though most are small and harmless. Once a cyst is spotted, additional imaging with MRCP or endoscopic ultrasound may be recommended to learn more about it.^[2][14]

Endoscopic Ultrasound (EUS)

For a more detailed look at a pancreatic cyst, doctors may recommend an endoscopic ultrasound, or EUS. This procedure combines endoscopy (using a thin, flexible tube with a camera) and ultrasound imaging. The tube is passed through your mouth and down into your stomach and small intestine, positioning the ultrasound probe very close to your pancreas. This proximity allows for extremely high-quality images that can reveal details not visible on other scans.^[1][10]

One major advantage of EUS is that it allows doctors to take a sample of fluid from the cyst if needed, using a technique called fine-needle aspiration, or FNA. During FNA, a thin needle is guided into the cyst while the doctor watches on the ultrasound screen. A small amount of fluid is withdrawn and sent to a laboratory for analysis. Testing this fluid can provide valuable information, such as the level of a protein called CEA (carcinoembryonic antigen), which tends to be elevated in IPMNs. The fluid can also be examined for abnormal cells and tested for genetic mutations that might indicate a higher risk of cancer.^[1][5]

Because EUS involves sedation and the passage of a tube through the digestive tract, it’s a bit more involved than MRCP or CT scans. However, it’s generally safe and well-tolerated. You’ll likely be asked to avoid eating or drinking for several hours before the procedure, and you’ll need someone to drive you home afterward because of the sedation.

Classifying IPMNs by Location

One of the most important aspects of diagnosing an IPMN is determining exactly where it’s located within the pancreas. The pancreas has a system of ducts that work like a branching tree. There’s one main pancreatic duct running through the center of the organ, with many smaller branch ducts feeding into it. IPMNs are classified based on which part of this duct system they affect.^[1][2]

Main duct IPMNs occur when the tumor grows in the main pancreatic duct, causing it to widen or dilate. Normally, this duct measures about 3.5 millimeters in diameter or less. If imaging shows that the main duct has expanded beyond this size and there’s no other explanation like blockage from a stone or tumor elsewhere, doctors suspect a main duct IPMN. These are the most concerning type because they have a much higher chance of being cancerous or becoming cancerous soon. Studies suggest that between 57 and 92 percent of main duct IPMNs are either already cancerous or contain high-grade precancerous changes.^[1][6]

Branch duct IPMNs are cysts that develop in one of the smaller branch ducts that feed into the main duct. These are more common than main duct IPMNs and generally carry a lower risk of cancer. Research indicates that branch duct IPMNs have about a 6 to 46 percent chance of becoming malignant, which is much lower than main duct types. Because of this lower risk, many branch duct IPMNs can be safely monitored with regular imaging rather than immediately removed with surgery.^[2][6]

Mixed type IPMNs involve both the main duct and branch ducts. These are treated more like main duct IPMNs because the involvement of the main duct raises the cancer risk significantly. When doctors see both components on imaging, they typically recommend surgery if the patient is healthy enough to undergo the procedure.^[2]

Additional Tests and Monitoring

Beyond imaging, doctors may order blood tests to check for markers that could indicate complications or cancer. One such test measures CA19-9, a protein that can be elevated in people with pancreatic cancer. However, this test isn’t perfect — CA19-9 can also be elevated in other conditions like pancreatitis, and some people with pancreatic cancer have normal levels. Still, it can provide additional information when combined with imaging results.^[19]

If you’ve had episodes of pancreatitis, your doctor might also check your amylase levels, an enzyme produced by the pancreas. Elevated amylase in the blood can indicate inflammation or blockage in the pancreas. Additionally, if you’re experiencing digestive problems, tests of your stool may be performed to look for signs of malabsorption, such as excess fat (steatorrhea), which can occur when the pancreas isn’t producing enough digestive enzymes.^[19]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or monitoring strategies for various diseases, including IPMNs. To participate in a clinical trial, patients must meet specific criteria established by the researchers. Diagnostic tests play a crucial role in determining whether someone is eligible to join a trial.

For IPMN clinical trials, the first requirement is usually confirmation that the patient actually has an IPMN rather than another type of pancreatic cyst. This is typically established through imaging studies like MRCP or CT scans, which show the characteristic features of an IPMN: a cystic growth within the pancreatic ducts that may be producing mucin. The location of the cyst — whether in the main duct, a branch duct, or both — is also important information for trial eligibility.^[1][12]

The size of the cyst is another key factor. Many clinical trials are designed to study IPMNs of a certain size, such as those larger than 3 centimeters or those that have specific features like a nodule (a solid bump) growing inside the cyst. Imaging tests can measure these features precisely. Nodules are particularly important because they can indicate a higher risk of cancer, and trials may specifically enroll patients with or without nodules depending on the research question.^[12]

Endoscopic ultrasound with fine-needle aspiration may be required for some clinical trials. The fluid collected from the cyst can be tested for the presence of certain genetic mutations. Researchers have identified that IPMNs often contain mutations in genes called KRAS and GNAS. These genetic changes can help distinguish IPMNs from other types of pancreatic cysts and may also provide information about the likelihood of the cyst becoming cancerous. Trials studying new treatments or monitoring strategies may require evidence of these specific mutations as part of their enrollment criteria.^[2][5]

Blood tests are also standard requirements for clinical trial participation. In addition to confirming that a patient has an IPMN, researchers need to ensure that participants are healthy enough to safely undergo the trial procedures or treatments. This typically includes blood tests to check liver function, kidney function, and blood cell counts. These tests ensure that a patient’s body can handle the trial requirements without undue risk.^[19]

For trials testing surgical approaches to IPMNs, additional diagnostic criteria may be necessary. For example, trials comparing different surgical techniques might require detailed imaging to map out the exact location and extent of the IPMN within the pancreas. This helps surgeons plan the procedure and ensures that all participants in the trial have comparable disease characteristics, which makes the research results more reliable and meaningful.

Some clinical trials focus on surveillance strategies — in other words, finding the best way to monitor IPMNs over time to catch any dangerous changes early. For these trials, patients typically need to have an IPMN that hasn’t yet shown signs of cancer. The diagnostic tests required would include imaging that confirms the cyst is stable and doesn’t have high-risk features like rapid growth, a large size, or the presence of a nodule. Patients may also need to undergo baseline endoscopic ultrasound so researchers have a starting point to compare future scans against.^[12]

It’s worth noting that clinical trial criteria can be quite specific, and not everyone with an IPMN will qualify for every trial. However, these strict requirements are necessary to ensure that research results are scientifically valid and can be applied to help future patients. If you’re interested in participating in a clinical trial, your doctor can help you understand which trials you might be eligible for based on your diagnostic test results and overall health.